Lv3
284 积分 2023-10-27 加入
miR-15a-5p enhances the malignant phenotypes of colorectal cancer cells through the STAT3/TWIST1 and PTEN/AKT signaling pathways by targeting SIRT4
6天前
已完结
MSI-H/dMMR mCRC: ICIs in the first line?
15天前
已完结
Tumour mutational burden: clinical utility, challenges and emerging improvements
17天前
已完结
Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab
24天前
已完结
Immune‐related adverse events after immune check point inhibitors: Understanding the intersection with autoimmunity
1个月前
已完结
Immune-related toxicities of checkpoint inhibitors: mechanisms and mitigation strategies
1个月前
已完结
Clinical and translational attributes of immune-related adverse events
1个月前
已完结
Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations
1个月前
已完结
Tumour-intrinsic resistance to immune checkpoint blockade
1个月前
已完结
皖公网安备34019202002308
